CQ Forum on Biosimilar Biological Products - Wed., Jun...( WASHINGTON June 15 -- Congressional ...)

WASHINGTON, June 15 /PRNewswire-USNewswire/ -- Congressional Quarterly presents a 360-degree look at the "state of play" on the approval of follow-on versions of biotech drugs. This CQ Forum will include a panel discussion with industry leaders, public interest groups, and leading researchers regarding the complex structures of biologics products vs. traditional pharmaceuticals. Are generic biologics possible? Will the availability of these products save money for consumers? What is the right length of intellectual property protection?

The event will be hosted by Congressional Quarterly and sponsored by Johnson & Johnson Pharmaceutical Services, L.L.C.

Keynote speakers include: Rep. Anna Eshoo (D-CA) and Sen. Orrin Hatch (R-UT).

Frank Sesno, professor of media and public affairs at The George Washington University and host of PBS's "Planet Forward" will moderate the panel discussion.

Panelists include:

• Alex Brill, Research Fellow, American Enterprise Institute
• Richard F. Kingham, Partner, Covington & Burling
• Jay P. Siegel, M.D., Chief Biotechnology Officer, Centocor
• Ann Witt, J.D., Health Counsel to Representative to Henry Waxman
• Gillian R. Woollett, M.A., D.Phil, Chief Scientist, Engel & Novitt, L.L.P.

To register, please visit www.cq.com/cqeventregistration. Space is limited.

    When:      Wed., Jun. 17, 2009
               8 to 8:30 a.m. - Breakfast and conversation
               8:30 to 11:30 a.m. - Program

    Where:     B. Smith's at Union Station
               50 Massachusetts Avenue, NE
               Washington, DC 20002